Jim Cramer's 'Mad Money' Recap: A Monster of an August

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK ( TheStreet) -- With the market near completing its best August in 14 years, Jim Cramer told his Mad Money viewers Tuesday there's not much to fear at these levels but there is still a lot to embrace.

Just how did the market achieve such remarkable gains? Cramer said that Monster Beverage (MNST) helped with its 36% gain and he would still be a buyer of the stock. Likewise with Mohawk Industries (MHK) and Gilead Sciences (GILD) , which were up 17% and 16%, respectively. Cramer said he's a fan of both companies, especially Gilead, which still trades at just 11 times earnings.

Cramer said he's also a fan of Ross Stores (ROST) and Gap Stores (GPS) , both of which are gaining steam as gas prices continue to fall.

Cramer is less enthusiastic about Dollar General's (DG) 15% gain for the month, saying that some of those gains will likely be given back in the coming weeks.

Other big winners for August included Tenet Healthcare (THC) and Keurig Green Mountain (GMCR) , along with Netflix (NFLX) , Southwest Airlines (LUV) , Masco (MAS) and Home Depot (HD) .

Finally, Cramer said he's a fan of Kinder Morgan (KMI) , a stock which he's buying for his charitable trust, Action Alerts PLUS.

Is Perrigo a Bargain?

Are there still bargains to be had with the markets at record highs? Cramer said there are if investors are considering private label drug maker Perrigo (PRGO) , a stock that's up 226% since he first got behind the stock four years ago.

After peaking in March, shares of Perrigo have declined due to manufacturing issues that lowered the company's earnings. But now that those issues are in the past, Cramer said this fantastic company should be ready to resume going higher.

Cramer said Perrigo products simply make sense for thrifty consumers. Why pay over $71 for a box of Nicorette gum, for example, when the identical Perrigo product sells for 26% less? Perrigo is a lot more than just over-the-counter medications -- it makes generic drugs and nutritional supplements.

With so many prescription drugs coming off patent in the coming years, Cramer said Perrigo will have no shortage of new products. The company will introduce 75 products this year alone.

Beyond its new product innovations, Cramer said Perrigo's newfound Irish tax status will also help boost earnings power and make the company an attractive takeover target for other companies looking for a tax inversion. Cramer said he sees Perrigo shares hitting $175 a share by the end of the year.

CSI: Cramer, the Sequel

For the second installment of "Cramer's Stock Investigation," or CSI, Cramer investigated five retail stocks that appear to have been the victims of a market hit-and-run.

Cramer said that DSW (DSW) saw its shares hammered 28% in a single day back in May when the company missed earnings. Since then the company and its shares have been making a comeback, capped off by this week's strong earnings announcement. This stock should never have been sold, Cramer concluded.

Then there's Sears Holdings (SHLD) , a stock without a pulse for many years. Even after divesting assets and closing stores Sears is still seeing sales and revenue declines. Cramer said this stock has too many problems and investors need to stay far away.

Lands' End (LE) , on the other hand, is a survivor, Cramer noted. Now that the company is free from Sears, he thinks the stock is a buy at just 15 times earnings.

Speaking of survivors, Cramer called the turnaround at Abercrombie & Fitch (ANF) "remarkable" and said this stock also should never have been sold in the first place.

Finally, Cramer said Ann (ANN) , formerly Ann Taylor, is benefiting from activist investors, which has prompted the company to consider selling itself to unlock value. Even without a sale, Cramer said this company has lots of options and could be worth $55 a share.

Executive Decision: Susan Salka

For his "Executive Decision" segment, Cramer sat down with Susan Salka, president and CEO of health care staffing company AMN Healthcare (AHS) , a stock that's gained 15% since Cramer last checked in back in November.

Salka said now that hospitals have some clarity on what the Affordable Care Act will mean for them, staffing levels are returning to normal but still with strong growth that is projected to continue. She said demand is up across the board across all clients and all regions of the country.

When asked what's driving the demand for health care professionals, Salka said the growing economy, an aging population and the wave of newly insured patients are all contributing to the need for more doctors and nurses. She said among the retiring baby boomers are a lot of retiring health care workers, and we're just not replacing them fast enough.

Cramer said these are all the reasons why he likes AMN and continues to recommend the stock.

Lightning Round

In the Lightning Round, Cramer was bullish on Cypress Semiconductor (CY) , CIGNA (CI) , Fiesta Restaurant Group (FRGI) , Intel (INTC) , Skyworks Solutions (SWKS) and WPX Energy (WPX) .

Cramer was bearish on Amedisys (AMED) , Carrols Restaurant Group (TAST) , CalAmp (CAMP) and Warren Resources (WRES) .

No Huddle Offense

In his "No Huddle Offense" segment, Cramer said "enough already" about the merger between Tim Horton's (THI) and Burger King (BKW) . He said investors looking for hot restaurants should just go own Starbucks (SBUX) or Chipotle Mexican Grill (CMG) , not two second-tier players.

Cramer said the Burger King deal stinks of desperation, as the company realizes the younger generation is rejecting its menu, making itself no longer viable another 10 years down the road. As for Hortons, it has delivered two bad quarters in a row with little to no good explanation.

Cramer said there's a tectonic shift in tastes occurring and it's occurring quickly, as Chipotle's 17% same-store sales growth proves. Burgers and donuts are on the way out, he said, and investors need to wake up and embrace that fact. Even Starbucks' solid 7% same-store sales growth is better than Hortons. Starbucks works around the globe, Cramer concluded, while Hortons doesn't even really work here in America.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
At the time of publication, Cramer's Action Alerts PLUS had a position in KMI and SBUX.

If you liked this article you might like

Incoming Perrigo CEO Brings Strong Operations Experience

Incoming Perrigo CEO Brings Strong Operations Experience

These Are the Biggest Winners and Losers in Activist Investing This Year

These Are the Biggest Winners and Losers in Activist Investing This Year

McDonald's Takes Bite Out of Dow, but Nasdaq and S&P 500 at Records

McDonald's Takes Bite Out of Dow, but Nasdaq and S&P 500 at Records

Perrigo Stock Jumps as Starboard's Smith Says Generic Drugs a Strong Business

Perrigo Stock Jumps as Starboard's Smith Says Generic Drugs a Strong Business

Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain

Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain